Bending the Acuity Curve
In a company-reported retrospective analysis at a southeast regional provider, 2,596 patients assessed for atherosclerotic cardiovascular disease began in the same Moderate Low Disease Progression Index category (Visión publication). Cogitativo reports that Visión’s trajectory analysis identified 649 patients whose disease complexity accelerated, with the predicted distinction assessed against their subsequent two-year course (Visión publication).
The clinical decision is whom to review earlier. The prediction informs that review; clinicians determine whether to intervene and what care is appropriate.
Company publication · May 2026
Summary prepared · Cogitativo
Who is progressing before current acuity reveals it?
The publication describes 52,000 patients eligible for atherosclerotic cardiovascular disease scoring in FY23. After applying its inclusion criteria, the analysis focused on 2,596 patients (Visión publication).
Current spending and acuity describe one state. A prediction concerns what follows over a defined period.
What the retrospective analysis examines
The publication compares the predicted distinction with what happened over the following two years. It reports divergence in clinical course and subsequent cost within the initially similar risk group (Visión publication).
Prediction and intervention results are separate
This is company-reported retrospective evidence about disease-progression prediction (Visión publication). The publication’s economic-return scenarios are projected; they do not establish that an intervention delivered the stated savings or improved clinical outcomes (Visión publication).
Read the original account
Read the Visión publication for the reported analysis and its projected economics. Explore Visión for its current clinical-foresight scope.
Visión publication: Bending the Acuity Curve